Focalin XR Starting Dose for 30-Year-Old Female
The recommended starting dose of Focalin XR for a 30-year-old female is 10 mg once daily in the morning. 1
FDA-Approved Adult Dosing
The FDA label for Focalin XR explicitly states that for adult patients who are new to methylphenidate or dexmethylphenidate, the starting dose is 10 mg/day, administered once daily in the morning. 1 This differs from the pediatric starting dose of 5 mg/day. 1
Titration Strategy
- Dose adjustments should be made in 10 mg increments for adult patients (compared to 5 mg increments in pediatric patients). 1
- Timing of adjustments should proceed at approximately weekly intervals, allowing sufficient time at each dose to assess maximal benefit before increasing. 1
- Maximum studied dose is 40 mg/day in adults; doses above this have not been studied and are not recommended. 1
Clinical Trial Evidence Supporting Adult Dosing
In a randomized, double-blind, placebo-controlled trial of 221 adults with ADHD, fixed doses of 20 mg, 30 mg, and 40 mg were all significantly superior to placebo in reducing ADHD Rating Scale scores. 2 All three doses demonstrated efficacy, with the 40 mg dose showing the greatest improvement (16.9-point reduction vs. 7.9 with placebo). 2 Long-term data from a 6-month open-label extension study confirmed that doses of 20-40 mg/day were safe and effective for sustained treatment of adult ADHD. 3
Important Pre-Treatment Considerations
Before initiating Focalin XR, obtain:
- Baseline vital signs: Blood pressure and pulse must be documented, as adults on stimulants require quarterly monitoring. 4
- Cardiovascular screening: Rule out essential hypertension and cardiac arrhythmias through history and physical examination. 4
- Weight baseline: Document starting weight to monitor for appetite suppression. 4
Administration Options
- Swallow whole or open capsule and sprinkle contents on applesauce for immediate consumption. 1
- Do not crush, chew, or divide the capsule or beads. 1
- Once-daily dosing in the morning provides symptom control throughout the day. 1
Common Pitfalls to Avoid
- Do not start at pediatric dose (5 mg): Adults require the higher 10 mg starting dose per FDA labeling. 1
- Do not use immediate-release dosing guidelines: The 2002 guidelines citing 5 mg MPH or 2.5 mg DEX/AMP starting doses apply to immediate-release formulations, not extended-release products. 4
- Avoid excessive dose escalation: While doses can go higher than PDR limits in rare cases, if 40 mg is ineffective, consider switching medications rather than further increasing the dose. 4
Monitoring Schedule
- Initial titration phase: Weekly contact (office visit or telephone) during the first 2-4 weeks while adjusting dose. 4
- Maintenance phase: Monthly appointments until symptoms stabilize, then adjust frequency based on response and tolerability. 4
- Vital signs: Check blood pressure and pulse quarterly throughout treatment. 4